China Biologic Products (CBPO)
Add to Watchlists Create an Alert
26.50
+0.10 +0.38%
NASDAQ
May 23, 4:57PM
BATS Real time
Currency in USD
China Biologic Products Accounts Receivable:
11.21M for Dec. 31, 2012China Biologic Products Historical Accounts Receivable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 11.21M |
| Sept. 30, 2012 | 14.96M |
| June 30, 2012 | 21.54M |
| March 31, 2012 | 24.74M |
| Dec. 31, 2011 | 16.76M |
| Sept. 30, 2011 | 19.12M |
| June 30, 2011 | 20.39M |
| March 31, 2011 | 13.31M |
| Dec. 31, 2010 | 10.13M |
| Sept. 30, 2010 | 6.338M |
| June 30, 2010 | 5.888M |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
CBPO Accounts Receivable Benchmarks
| Companies | |
|---|---|
| Acorda Therapeutics | 23.29M |
| Vanda Pharmaceuticals | 1.168M |
| Theravance | 1.963M |
CBPO Accounts Receivable Rankings
| Overall |
67th percentile 2580 of 8006 |
| Sector |
67th percentile 225 of 686 in Healthcare |
| Industry |
85th percentile 37 of 248 in Biotechnology |
CBPO Accounts Receivable Range, Past 5 Years
| Minimum | 0.3131M | Dec 2008 |
| Maximum | 24.74M | Mar 2012 |
| Average | 9.294M |